An approach on current regulatory considerations of adverse event reporting & pharmacovigilance for biologics in India and US

By:

Material type: Text

TextDescription: viii, 148Dissertation note: MADHAVI B.L.R.

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Call number	Status	Date due	Barcode
ACP-Thesis & Dissertations	Acharya & BM Reddy College of Pharmacy Reference	Acharya & BM Reddy College of Pharmacy	ACP-Thesis and Dissertations	615.19 AGR (Browse shelf(Opens below))	Not for loan		ACP-T592

Previous	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	Next
Previous	615.190 068 5 KOT Application of QBD as a strategic tool for the risk analysis of flunarizine tablets preparation	615.190 068 5 PRA Process design & qualification: Relative impact of formulation variables on quality attributes of antihypertensive sublingual tablets	615.190 1 NAV Evaluation of chemical compatibility of tablet excipients with ondansetron using HPLC method	615.19 AGR An approach on current regulatory considerations of adverse event reporting & pharmacovigilance for biologics in India and US	615.19 ANU Regulatory processes for import & export of pharmaceutical product in India	615.19 CHE Design synthesis and anticancer study of novel heterocyclic componds as a B-RAF inhibitors for the treatment	615.19 DAS Pyrimidine-quinazoline based discoidin domain receptor inhibitors: Design Synthesis & in-vitro anti-cancer study.	Next

MADHAVI B.L.R.

There are no comments on this title.

to post a comment.